Single German centre experience with patient journey and care-relevant needs in amyloidosis : The German AMY-NEEDS research and care program
(2024) In PLoS ONE 19(5 May).- Abstract
Background Amyloidosis is a rare multi-system disorder associated with frequently delayed diagnosis, enormous disease burden and psychosocial distress. Methods Systematic assessment of needs was performed by a subtype-spanning questionnairebased survey within the AMY-NEEDS research and care program. Results 118 patients with proven amyloidosis (62.7% ATTR, 22.0% AL, 15.3% other forms) were included in August 2020 until February 2021 (mean age 71.2 ±11.3 years; 30% women). The median diagnostic delay between onset of symptoms and diagnosis was 9.0 (range: 2.5; 33.0) months. Local health care providers (HCPs) play a central role on the way to diagnosis. Diagnosis itself typically requires a clinical but not necessarily a university... (More)
Background Amyloidosis is a rare multi-system disorder associated with frequently delayed diagnosis, enormous disease burden and psychosocial distress. Methods Systematic assessment of needs was performed by a subtype-spanning questionnairebased survey within the AMY-NEEDS research and care program. Results 118 patients with proven amyloidosis (62.7% ATTR, 22.0% AL, 15.3% other forms) were included in August 2020 until February 2021 (mean age 71.2 ±11.3 years; 30% women). The median diagnostic delay between onset of symptoms and diagnosis was 9.0 (range: 2.5; 33.0) months. Local health care providers (HCPs) play a central role on the way to diagnosis. Diagnosis itself typically requires a clinical but not necessarily a university setting. In the treatment phase, the focus moves to the amyloidosis centre as primary contact and coordinator, with general practitioners (GPs) acting predominantly as a contact point in crisis and link to additional services. About half of patients reported impaired quality of life and one third suffering from anxiety and depressed mood, respectively. The majority of patients talk about their concerns with close caregivers and local HCPs. Advance care planning is a relevant, yet insufficiently met need. Conclusion The journey of patients with amyloidotic disease, their contact partners and needs at different stages were characterized in detail within the German health care system. An amyloidosis- specific care concept has to master the multitude of interfaces connecting the numerous treatment providers involved with the amyloidosis centre and GPs as key players. Telemedical approaches could be a promising and well-accepted option allowing optimal coordination and communication.
(Less)
- author
- Ihne-Schubert, Sandra Michaela LU ; Leberzammer, Maria ; Weidgans, Marcel ; Frantz, Stefan ; Einsele, Hermann ; Knop, Stefan ; Schubert, Torben LU ; Bratan, Tanja ; Störk, Stefan and Neuderth, Silke
- organization
- publishing date
- 2024-05
- type
- Contribution to journal
- publication status
- published
- subject
- in
- PLoS ONE
- volume
- 19
- issue
- 5 May
- article number
- e0297182
- publisher
- Public Library of Science (PLoS)
- external identifiers
-
- scopus:85193633322
- pmid:38768126
- ISSN
- 1932-6203
- DOI
- 10.1371/journal.pone.0297182
- language
- English
- LU publication?
- yes
- id
- cd49e5b9-648e-40e7-94fa-551df6df3f6c
- date added to LUP
- 2024-05-31 10:39:13
- date last changed
- 2024-06-14 11:33:24
@article{cd49e5b9-648e-40e7-94fa-551df6df3f6c,
abstract = {{<p>Background Amyloidosis is a rare multi-system disorder associated with frequently delayed diagnosis, enormous disease burden and psychosocial distress. Methods Systematic assessment of needs was performed by a subtype-spanning questionnairebased survey within the AMY-NEEDS research and care program. Results 118 patients with proven amyloidosis (62.7% ATTR, 22.0% AL, 15.3% other forms) were included in August 2020 until February 2021 (mean age 71.2 ±11.3 years; 30% women). The median diagnostic delay between onset of symptoms and diagnosis was 9.0 (range: 2.5; 33.0) months. Local health care providers (HCPs) play a central role on the way to diagnosis. Diagnosis itself typically requires a clinical but not necessarily a university setting. In the treatment phase, the focus moves to the amyloidosis centre as primary contact and coordinator, with general practitioners (GPs) acting predominantly as a contact point in crisis and link to additional services. About half of patients reported impaired quality of life and one third suffering from anxiety and depressed mood, respectively. The majority of patients talk about their concerns with close caregivers and local HCPs. Advance care planning is a relevant, yet insufficiently met need. Conclusion The journey of patients with amyloidotic disease, their contact partners and needs at different stages were characterized in detail within the German health care system. An amyloidosis- specific care concept has to master the multitude of interfaces connecting the numerous treatment providers involved with the amyloidosis centre and GPs as key players. Telemedical approaches could be a promising and well-accepted option allowing optimal coordination and communication.</p>}},
author = {{Ihne-Schubert, Sandra Michaela and Leberzammer, Maria and Weidgans, Marcel and Frantz, Stefan and Einsele, Hermann and Knop, Stefan and Schubert, Torben and Bratan, Tanja and Störk, Stefan and Neuderth, Silke}},
issn = {{1932-6203}},
language = {{eng}},
number = {{5 May}},
publisher = {{Public Library of Science (PLoS)}},
series = {{PLoS ONE}},
title = {{Single German centre experience with patient journey and care-relevant needs in amyloidosis : The German AMY-NEEDS research and care program}},
url = {{http://dx.doi.org/10.1371/journal.pone.0297182}},
doi = {{10.1371/journal.pone.0297182}},
volume = {{19}},
year = {{2024}},
}